Adya provides the TARA technology platform, which leverages Artificial Intelligence to improve patient and caregiver adoption rates for specific high-value therapies. This platform is designed to solve cognitive friction in patient activation and engagement through a proprietary interface. The core value proposition is boosting treatment persistency, which directly enhances product Net Present Values and shareholder equity for emerging biopharma companies.
Funding
$2.5M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Cancer patients often experience prolonged recovery times and high healthcare costs due to a lack of focus on resiliency and rehabilitation after treatment. This can lead to recurring billable encounters and a slower return to normal life.
Solution
Adya provides a platform designed to accelerate cancer recovery and improve patient resiliency through personalized pathways. Developed in collaboration with Massachusetts General Hospital, the platform combines behavioral health and technology to address the gap between cancer treatment and recovery. By focusing on improving fundamental health indicators, Adya aims to reduce healthcare costs and improve the quality of life for cancer survivors, helping them return to work and daily activities more quickly. The platform offers a user-friendly interface with pathways that integrate sentiments and science, fostering a supportive micro-community and providing measurable results.
Target Audience
Adya's primary customers include insurers looking to reduce costs, employers aiming to improve employee productivity, care providers seeking to extend their services, and governments wanting to improve population health outcomes.
Features
- Personalized resiliency pathways developed with a leading healthcare institution.
- Digital engagement platform designed for cancer survivors and older adults.
- Integration of psychometrics, biometrics, and data science for real-time personalization.
- Pathways that combine sentiments and science.
- Micro-community feature to connect patients with champions.
- Tools to see, feel, and measure progress.